Lakeshore Financial Planning’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-355
Closed -$277K 84
2025
Q2
$277K Buy
355
+95
+37% +$73.8K 0.11% 57
2025
Q1
$215K Buy
+260
New +$216K 0.09% 71
2024
Q4
Sell
-360
Closed -$319K 80
2024
Q3
$319K Buy
+360
New +$324K 0.14% 51
2023
Q4
Sell
-489
Closed -$263K 66
2023
Q3
$263K Buy
+489
New +$252K 0.15% 48

Other funds holding LLY

Lakeshore Financial Planning's LLY Position: Q3 2025 in Review

Lakeshore Financial Planning sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 355 shares — an estimated $277K sold.

Lakeshore Financial Planning first reported a position in LLY in Q3 2023 and held it in 4 quarters. The position peaked at $319K in Q3 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Lakeshore Financial Planning reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Lakeshore Financial Planning sold 355 Eli Lilly shares in Q3 2025, an estimated $277K.
  • Lakeshore Financial Planning first reported a position in Eli Lilly in Q3 2023 and held it in 4 quarters.
  • Lakeshore Financial Planning's Eli Lilly position peaked at $319K in Q3 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Lakeshore Financial Planning's 13F filing for Q3 2025, filed 14 Nov 2025.